pubmed.ncbi.nlm.nih.gov

Chasing phosphohistidine, an elusive sibling in the phosphoamino acid family - PubMed

  • ️Sun Jan 01 2012

Review

. 2012 Jan 20;7(1):44-51.

doi: 10.1021/cb200445w. Epub 2011 Dec 9.

Affiliations

Review

Chasing phosphohistidine, an elusive sibling in the phosphoamino acid family

Jung-Min Kee et al. ACS Chem Biol. 2012.

Abstract

This year (2012) marks the 50th anniversary of the discovery of protein histidine phosphorylation. Phosphorylation of histidine (pHis) is now widely recognized as being critical to signaling processes in prokaryotes and lower eukaryotes. However, the modification is also becoming more widely reported in mammalian cellular processes and implicated in certain human disease states such as cancer and inflammation. Nonetheless, much remains to be understood about the role and extent of the modification in mammalian cell biology. Studying the functional role of pHis in signaling, either in vitro or in vivo, has proven devilishly hard, largely due to the chemical instability of the modification. As a consequence, we are currently handicapped by a chronic lack of chemical and biochemical tools with which to study histidine phosphorylation. Here, we discuss the challenges associated with studying the chemical biology of pHis and review recent progress that offers some hope that long-awaited biochemical reagents for studying this elusive posttranslational modification (PTM) might soon be available.

PubMed Disclaimer

Figures

Figure 1
Figure 1

Structure and chemistry of pHis.

Figure 2
Figure 2

Stable pHis analogs

Figure 3
Figure 3

a) Design and synthesis of pTza as pHis analogs. b) Peptide dot blots using anti-τ-pHis18 antibody. c) Western blots of chemically histidine-phosphorylated histone H4. Adapted with permission from reference . Copyright (2010) American Chemical Society.

Similar articles

Cited by

References

    1. Walsh CT. Posttranslational Modification of Proteins: Expanding Nature's Inventory. Greenwood Village: Roberts and Company Publishers; 2006.
    1. Druker BJ. Molecularly targeted therapy: Have the floodgates opened? The Oncologist. 2004;9:357–360. - PubMed
    1. Cohen P. Protein kinases--the major drug targets of the twenty-first century? Nat. Rev. Drug Discovery. 2002;1:309–315. - PubMed
    1. Boyer PD, Peter JB, Ebner KE, Deluca M, Hultquist D. Identification of phosphohistidine in digests from a probable intermediate of oxidative phosphorylation. J. Biol. Chem. 1962;237:3306–3308. - PubMed
    1. Eckhart W, Hutchinson MA, Hunter T. An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates. Cell. 1979;18:925–933. - PubMed

Publication types

MeSH terms

Substances